FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Monath

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Neutralization Tests

Anatomy

Vero Cells

Co-author Network

Publications

TOP 3
Thomas P Monath
Review of the risks and benefits of yellow fever vaccination including some new analyses.
Evgeniya Volkova; Thomas P Monath; Robert B Tesh; Nikos Vasilakis
Full genomic sequence of the prototype strain (M64) of Rio Bravo virus.
Allison Kay; Lin H Chen; Maggie Sisti; Thomas P Monath
Yellow fever vaccine seroconversion in travelers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Monath (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Thomas P Monath
Review of the risks and benefits of yellow fever vaccination including some new analyses.
Expert review of vaccines 2012;11(4):427-48.
2012: Evgeniya Volkova; Thomas P Monath; Robert B Tesh; Nikos Vasilakis
Full genomic sequence of the prototype strain (M64) of Rio Bravo virus.
Journal of virology 2012;86(8):4715.
2011: Allison Kay; Lin H Chen; Maggie Sisti; Thomas P Monath
Yellow fever vaccine seroconversion in travelers.
The American journal of tropical medicine and hygiene 2011;85(4):748-9.
2011: Emily S Jentes; Johan Lemarchand; Rosamund F Lewis; Thomas P Monath; Gilles Poumerol; J Erin Staples; Oyewale TOMORI; Annelies Wilder-Smith; Mark D Gershman; David R Hill
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
The Lancet infectious diseases 2011;11(8):622-32.
2011: Thomas P Monath; Elizabeth Fowler; Casey T Johnson; John Balser; Merribeth J Morin; Maggie Sisti; Dennis W Trent
An inactivated cell-culture vaccine against yellow fever.
The New England journal of medicine 2011;364(14):1326-33.
2011: Heidi L Smith; Thomas P Monath; Pamela Pazoles; Alan L Rothman; Diane M Casey; Masanori Terajima; Francis A Ennis; Farshad Guirakhoo; Sharone Green
Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination.
The Journal of infectious diseases 2011;203(4):513-22.
2010: Thomas P Monath; Cynthia K Lee; Justin G Julander; Alicja Brown; David W Beasley; Douglas M Watts; Edward Hayman; Patrick Guertin; Joseph Makowiecki; Joseph Crowell; Philip Levesque; Gavin C Bowick; Merribeth Morin; Elizabeth Fowler; Dennis W Trent
Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity.
Vaccine 2010;28(22):3827-40.
2010: Thomas P Monath
Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States.
The American journal of tropical medicine and hygiene 2010;82(5):919-21.
2010: Bruno Guy; Farshad Guirakhoo; Veronique Barban; Stephen Higgs; Thomas P Monath; Jean Lang
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Vaccine 2010;28(3):632-49.
2010: Thomas P Monath; Laura H Kahn; Bruce Kaplan
Introduction: one health perspective.
ILAR journal / National Research Council, Institute of Laboratory Animal Resources 2010;51(3):193-8.
2009: Barbara W Johnson; Olga Kosoy; Elizabeth A Hunsperger; Manuela Beltran; Mark Delorey; Farshad Guirakhoo; Thomas P Monath
Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.
Clinical and vaccine immunology : CVI 2009;16(7):1052-9.
2009: Sharon E Frey; Frances K Newman; Jeffrey S Kennedy; Francis Ennis; Getahun Abate; Daniel F Hoft; Thomas P Monath
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Vaccine 2009;27(10):1637-44.
2009: Thomas P Monath; Sharon E Frey
Possible autoimmune reactions following smallpox vaccination: the biologic false positive test for syphilis.
Vaccine 2009;27(10):1645-50.
2009: Thomas P Monath; Mark Gershman; David R Hill; Nina Marano; J Erin Staples; Annelies Wilder-Smith
Yellow fever recommendations for tourists to Kenya: a flawed risk assessment.
Journal of travel medicine 2009;16(2):146; author reply 146-7.
2009: Laura H Kahn; Bruce Kaplan; Thomas P Monath
In memoriam: Great 21st century physician 'One Health' leader dies - Ronald M. Davis, MD, Past President, American Medical Association.
Veterinaria italiana 2009;45(1):209.
2009: Laura H Kahn; Bruce Kaplan; Thomas P Monath
'One health' in action series: nos 1-8.
Veterinaria italiana 2009;45(1):195-208.
2009: Bruce Kaplan; Laura H Kahn; Thomas P Monath
The brewing storm.
Veterinaria italiana 2009;45(1):9-18.
2009: Bruce Kaplan; Thomas P Monath; Laura H Kahn; Jack Woodall
'ONE HEALTH' and parasitology.
Parasites & vectors 2009;2(1):36.
2009: Nicholas Komar; Stanley Langevin; Thomas P Monath
Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera.
Clinical and vaccine immunology : CVI 2009;16(1):134-5.
2008: J Erin Staples; Thomas P Monath
Yellow fever: 100 years of discovery.
JAMA : the journal of the American Medical Association 2008;300(8):960-2.
2008: Bruno Guy; Farshad Guirakhoo; Michael Watson; Stephen Higgs; Thomas P Monath
Safety of flavivirus chimeric vaccines: answer to Ishikawa et al. [Vaccine 26 (22) (2008) 2772-2781].
Vaccine 2008;26(33):4107-8.
2008: Lonnie J King; Larry R Anderson; Carina G Blackmore; Michael J Blackwell; Elizabeth A Lautner; Leonard C Marcus; Travis E Meyer; Thomas P Monath; James E Nave; Joerg Ohle; Marguerite Pappaioanou; Justin Sobota; William S Stokes; Ronald M Davis; Jay H Glasser; Roger K Mahr
Executive summary of the AVMA One Health Initiative Task Force report.
Journal of the American Veterinary Medical Association 2008;233(2):259-61.
2008: Thomas P Monath
Treatment of yellow fever.
Antiviral research 2008;78(1):116-24.
2008: Laura H Kahn; Bruce Kaplan; Thomas P Monath; James H Steele
Teaching "one medicine, one health".
The American journal of medicine 2008;121(3):169-70.
2008: Folorunso Oludayo Fasina; Bruce Kaplan; Laura H Kahn; Thomas P Monath
Improving vaccine coverage in Africa.
Lancet 2008;371(9610):386.
2008: Kathleen A Marriott; Christopher V Parkinson; Samantha I Morefield; Robert Davenport; Richard Nichols; Thomas P Monath
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.
Vaccine 2008;26(4):581-8.
2007: Thomas P Monath
Dengue and yellow fever--challenges for the development and use of vaccines.
The New England journal of medicine 2007;357(22):2222-5.
2007: Konstantin V Pugachev; Julia Schwaiger; Nathan Brown; Zhen-xi Zhang; John Catalan; Fred Mitchell; Simeon W Ocran; Alexander A Rumyantsev; Alexander A Khromykh; Thomas P Monath; Farshad Guirakhoo
Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).
Vaccine 2007;25(37-38):6661-71.
2007: Caroline C Maier; Simon Delagrave; Zhen-xi Zhang; Nathan Brown; Thomas P Monath; Konstantin V Pugachev; Farshad Guirakhoo
A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus.
Virology 2007;362(2):468-74.
2007: Alan D T Barrett; Thomas P Monath; Veronique Barban; Matthias Niedrig; Dirk E Teuwen
17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.
Vaccine 2007;25(15):2758-65.
2007: Shengqiang Li; Emily Locke; Joseph Bruder; David Clarke; Denise L Doolan; Menzo J E Havenga; Adrian V S Hill; Peter Liljestrom; Thomas P Monath; Hussein Y Naim; Christian Ockenhouse; De-chu C Tang; Kent R Van Kampen; Jean-Francois Viret; Fidel Zavala; Filip Dubovsky
Viral vectors for malaria vaccine development.
Vaccine 2007;25(14):2567-74.
2006: Stephen Higgs; Dana L Vanlandingham; Kimberly A Klingler; Kate L McElroy; Charles E McGee; Laura Harrington; Jean Lang; Thomas P Monath; Farshad Guirakhoo
Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand.
The American journal of tropical medicine and hygiene 2006;75(5):986-93.
2006: Mark Reid; Donna Mackenzie; Andrew Baron; Natalie Lehmann; Kym Lowry; John Aaskov; Farshad Guirakhoo; Thomas P Monath
Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE).
The American journal of tropical medicine and hygiene 2006;75(4):659-63.
2006: Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas H Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Irene Bosch; Sharone Green; Philip Bedford
A live, attenuated recombinant West Nile virus vaccine.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6694-9.
2006: James H Stark; Sharon E Frey; Paul S Blum; Thomas P Monath
Lack of transmission of vaccinia virus.
Emerging infectious diseases 2006;12(4):698-700.
2006: Farshad Guirakhoo; Scott Kitchener; Dennis Morrison; Remi Forrat; Karen McCarthy; Richard Nichols; Sutee Yoksan; Xiaochu Duan; Thomas H Ermak; Niranjan Kanesa-Thasan; Philip Bedford; Jean Lang; Marie-Jose Quentin-Millet; Thomas P Monath
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Human vaccines 2006;2(2):60-7.
2005: Getahun Abate; Joy Eslick; Frances K Newman; Sharon E Frey; Robert B Belshe; Thomas P Monath; Daniel F Hoft
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.
The Journal of infectious diseases 2005;192(8):1362-71.
2005: Konstantin V Pugachev; Farshad Guirakhoo; Thomas P Monath
New developments in flavivirus vaccines with special attention to yellow fever.
Current opinion in infectious diseases 2005;18(5):387-94.
2005: Thomas P Monath; Martin S Cetron; Karen McCarthy; Richard Nichols; W Tad Archambault; Leisa Weld; Philip Bedford
Yellow fever 17D vaccine safety and immunogenicity in the elderly.
Human vaccines 2005;1(5):207-14.
2005: Thomas P Monath; Gwendolyn A Myers; Robert A Beck; Michael Knauber; Kelly Scappaticci; Thad Pullano; W Tad Archambault; John Catalan; Chuck Miller; Zhen-Xi Zhang; Sunheang Shin; Konstantin V Pugachev; Ken Draper; Inessa Levenbook; Farshad Guirakhoo
Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
Biologicals : journal of the International Association of Biological Standardization 2005;33(3):131-44.
2005: Thomas P Monath
Yellow fever vaccine.
Expert review of vaccines 2005;4(4):553-74.
2005: Thomas P Monath; Karl M Johnson
In Memoriam. Patricia Ann Webb (1925-5005).
Archives of virology 2005;150(6):1268-70.
2005: Andrew W Artenstein; Casey Johnson; Thomas C Marbury; Dennis Morrison; Paul S Blum; Tracy Kemp; Richard Nichols; John P Balser; Michelle Currie; Thomas P Monath
A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.
Vaccine 2005;23(25):3301-9.
2005: Cheryl H Dean; Jason B Alarcon; Andrea M Waterston; Ken Draper; Richard Early; Farshad Guirakhoo; Thomas P Monath; John A Mikszta
Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates.
Human vaccines 2005;1(3):106-11.
2005: Thomas P Monath; Niranjan Kanesa-Thasan; Farshad Guirakhoo; Konstantin V Pugachev; Jeffrey Almond; Jean Lang; Marie-Jose Quentin-Millet; Alan D T Barrett; Margo A Brinton; Martin S Cetron; Rachel S Barwick; Thomas J Chambers; Scott B Halstead; John T Roehrig; Richard M Kinney; Rebecca R Rico-Hesse; James H Strauss
Recombination and flavivirus vaccines: a commentary.
Vaccine 2005;23(23):2956-8.
2005: Stavros Sougioultzis; Lorraine Kyne; Denise Drudy; Sarah Keates; Seema Maroo; Charalabos Pothoulakis; Paul J Giannasca; Cynthia K Lee; Michel Warny; Thomas P Monath; Ciarán P Kelly
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.
Gastroenterology 2005;128(3):764-70.
2005: Vivian E Belmusto-Worn; Jose L Sanchez; Karen McCarthy; Richard Nichols; Christian T Bautista; Alan J Magill; Giovanna Pastor-Cauna; Carlos Echevarria; Victor A Laguna-Torres; Billey K Samame; Maria E Baldeon; James P Burans; James G Olson; Philip Bedford; Scott Kitchener; Thomas P Monath
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
The American journal of tropical medicine and hygiene 2005;72(2):189-97.
2005: Casey Johnson; Thomas P Monath; Niranjan Kanesa-Thasan; Danell Mathis; Chuck Miller; Seth Shapiro; Richard Nichols; Karen McCarthy; Alison Deary; Philip Bedford
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trial.
Human vaccines 2005;1(1):24-9.
2005: Thomas P Monath
Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser.
Vector borne and zoonotic diseases (Larchmont, N.Y.) 2005;5(3):300-4.
2005: Samantha Brandler; Nathan Brown; Thomas H Ermak; Fred Mitchell; Megan Parsons; Zhenxi Zhang; Jean Lang; Thomas P Monath; Farshad Guirakhoo
Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells.
The American journal of tropical medicine and hygiene 2005;72(1):74-81.
2004: Konstantin V Pugachev; Farshad Guirakhoo; Fred Mitchell; Simeon W Ocran; Megan Parsons; Barbara W Johnson; Olga Kosoy; Robert S Lanciotti; John T Roehrig; Dennis W Trent; Thomas P Monath
Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool.
The American journal of tropical medicine and hygiene 2004;71(5):639-45.
2004: Juan Arroyo; Chuck Miller; John Catalan; Gwendolyn A Myers; Marion S Ratterree; Dennis W Trent; Thomas P Monath
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.
Journal of virology 2004;78(22):12497-507.
2004: Julian E Thomas; J E G Bunn; Harry Kleanthous; Thomas P Monath; Marilyn Harding; W Andy Coward; Lawrence T Weaver
Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(8):1155-60.
2004: Thomas P Monath; Joseph R Caldwell; Wolfgang Mundt; Joan Fusco; Casey S Johnson; Mark Buller; Jian Liu; Bridget Gardner; Greg Downing; Paul S Blum; Tracy Kemp; Richard Nichols; Richard Weltzin
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2004;8 Suppl 2():S31-44.
2004: David W C Beasley; Li Li; Suderman Miguel; Farshad Guirakhoo; Dennis W Trent; Thomas P Monath; Robert E Shope; Alan D T Barrett
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
Vaccine 2004;22(27-28):3722-6.
2004: Farshad Guirakhoo; Zhenxi Zhang; G Myers; Barbara W Johnson; Konstantin V Pugachev; Richard Nichols; Nathan Brown; Inessa Levenbook; Ken Draper; S Cyrek; Jean Lang; C Fournier; B Barrere; Simon Delagrave; Thomas P Monath
A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
Journal of virology 2004;78(18):9998-10008.
2004: Farshad Guirakhoo; Konstantin V Pugachev; Zhenxi Zhang; G Myers; Inessa Levenbook; Ken Draper; Jean Lang; Simeon W Ocran; Fred Mitchell; Megan Parsons; Nathan Brown; Samantha Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; Richard Nichols; Dennis W Trent; Thomas P Monath
Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.
Journal of virology 2004;78(9):4761-75.
2004: Barbara W Johnson; Trudy V Chambers; Mary B Crabtree; Farshad Guirakhoo; Thomas P Monath; Barry R Miller
Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.
The American journal of tropical medicine and hygiene 2004;70(1):89-97.
2004: Konstantin V Pugachev; Farshad Guirakhoo; Simeon W Ocran; Fred Mitchell; Megan Parsons; Caroline Penal; Soheila Girakhoo; Svetlana O Pougatcheva; Juan Arroyo; Dennis W Trent; Thomas P Monath
High fidelity of yellow fever virus RNA polymerase.
Journal of virology 2004;78(2):1032-8.
2003: Yelda Leal-Herrera; Javier Torres; Thomas P Monath; Irma Ramos; Alejandro Gomez; Armando Madrazo-de la Garza; Margarita Dehesa Violante; Onofre Muñoz
High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection.
The American journal of gastroenterology 2003;98(11):2395-402.
2003: Giselle Soto; Christian T Bautista; Daniel E Roth; Robert H Gilman; Billie Velapatiño; Masako Ogura; Giedrius Dailide; Manuel Razuri; Rina Meza; Uriel Katz; Thomas P Monath; Douglas E Berg; David N Taylor
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy.
The Journal of infectious diseases 2003;188(9):1263-75.
2003: Thomas P Monath; Farshad Guirakhoo; Richard Nichols; Sutee Yoksan; Robert Schrader; Chris Murphy; Paul Blum; Stephen Woodward; Karen McCarthy; Danell Mathis; Casey Johnson; Philip Bedford
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
The Journal of infectious diseases 2003;188(8):1213-30.
2003: Barbara W Johnson; Trudy V Chambers; Mary B Crabtree; J Arroyo; Thomas P Monath; Barry R Miller
Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes.
Medical and veterinary entomology 2003;17(3):235-43.
2003: Richard Weltzin; Jian Liu; Konstantin V Pugachev; Gwendolyn A Myers; Brie Coughlin; Paul S Blum; Richard Nichols; Casey Johnson; John Cruz; Jeffrey S Kennedy; Irene Bosch; Thomas P Monath
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.
Nature medicine 2003;9(9):1125-30.
2003: Stanley A Langevin; Juan Arroyo; Thomas P Monath; Nicholas Komar
Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus).
The American journal of tropical medicine and hygiene 2003;69(1):78-80.
2003: Konstantin V Pugachev; Farshad Guirakhoo; Dennis W Trent; Thomas P Monath
Traditional and novel approaches to flavivirus vaccines.
International journal for parasitology 2003;33(5-6):567-82.
2003: Samer Aboudola; Karen L Kotloff; Lorraine Kyne; Michel Warny; Eoin C Kelly; Stavros Sougioultzis; Paul J Giannasca; Thomas P Monath; Ciarán P Kelly
Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.
Infection and immunity 2003;71(3):1608-10.
2003: Ching-Juh Lai; Thomas P Monath
Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
Advances in virus research 2003;61():469-509.
2003: Alan D T Barrett; Thomas P Monath
Epidemiology and ecology of yellow fever virus.
Advances in virus research 2003;61():291-315.
2003: Thomas P Monath; Alan D T Barrett
Pathogenesis and pathophysiology of yellow fever.
Advances in virus research 2003;60():343-95.
2003: Thomas J Chambers; Thomas P Monath
Preface to volume 60 the flaviviruses: pathogenesis and immunity.
Advances in virus research 2003;60():xiii-xiv.
2003: Thomas J Chambers; Thomas P Monath
Preface to the flaviviruses.
Advances in virus research 2003;60():ix-xi.
2002: Stavros Sougioultzis; Cynthia K Lee; Mazen Alsahli; Subhas Banerjee; Michel Cadoz; Robert Schrader; Bruno Guy; Philip Bedford; Thomas P Monath; Ciarán P Kelly; Pierre Michetti
Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.
Vaccine 2002;21(3-4):194-201.
2002: Robert B Tesh; Juan Arroyo; Amelia P A Travassos da Rosa; Hilda Guzman; Shu-Yuan Xiao; Thomas P Monath
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model.
Emerging infectious diseases 2002;8(12):1392-7.
2002: Martin S Cetron; Anthony A Marfin; Kathleen G Julian; Duane J Gubler; Donald J Sharp; Rachel S Barwick; Leisa Weld; Robert Chen; Richard D Clover; Jaime Deseda-Tous; Victor Marchessault; Paul A Offit; Thomas P Monath
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2002;51(RR-17):1-11; quiz CE1-4.
2002: Barbara W Johnson; Trudy V Chambers; Mary B Crabtree; Tejal R Bhatt; Farshad Guirakhoo; Thomas P Monath; Barry R Miller
Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes.
The American journal of tropical medicine and hygiene 2002;67(3):260-5.
2002: Patricia Londoño-Arcila; Donna Freeman; Harry Kleanthous; Aisling M O'Dowd; Susan Lewis; Arthur K Turner; Emma L Rees; Timothy John Tibbitts; Judith Greenwood; Thomas P Monath; Michael J Darsley
Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Infection and immunity 2002;70(9):5096-106.
2002: Farshad Guirakhoo; Konstantin V Pugachev; Juan Arroyo; Chuck Miller; Zhen-Xi Zhang; Richard Weltzin; KM Georgakopoulos; John Catalan; Simeon W Ocran; Ken Draper; Thomas P Monath
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
Virology 2002;298(1):146-59.
2002: Thomas P Monath; Martin S Cetron
Prevention of yellow fever in persons traveling to the tropics.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(10):1369-78.
2002: Thomas P Monath; Richard Nichols; W Tad Archambault; Linda Moore; Ron Marchesani; Jason Tian; Robert E Shope; Nicola Thomas; Robert Schrader; Dean Furby; Philip Bedford
Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.
The American journal of tropical medicine and hygiene 2002;66(5):533-41.
2002: Thomas P Monath
Editorial: jennerian vaccination against West Nile virus.
The American journal of tropical medicine and hygiene 2002;66(2):113-4.
2002: Thomas P Monath; Juan Arroyo; Inessa Levenbook; Zhen-Xi Zhang; John Catalan; Ken Draper; Farshad Guirakhoo
Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
Journal of virology 2002;76(4):1932-43.
2002: Thomas P Monath; Karen McCarthy; Philip Bedford; Casey T Johnson; Richard Nichols; Sutee Yoksan; Ron Marchesani; Michael Knauber; Keith H Wells; Juan Arroyo; Farshad Guirakhoo
Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.
Vaccine 2002;20(7-8):1004-18.
2002: Konstantin V Pugachev; Simeon W Ocran; Farshad Guirakhoo; Dean Furby; Thomas P Monath
Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.
Vaccine 2002;20(7-8):996-9.
2002: Thomas P Monath
Japanese encephalitis vaccines: current vaccines and future prospects.
Current topics in microbiology and immunology 2002;267():105-38.
2001: Ricardo Galler; Konstantin V Pugachev; Cecília L S Santos; Simeon W Ocran; Alfredo V Jabor; Sueli Guerreiro Rodrigues; Renato S Marchevsky; Marcos S Freire; Luís F C Almeida; Ana Cecília R Cruz; Anna M Y Yamamura; Iray Maria Rocco; Elizabeth Salbé Travassos da Rosa; L T Souza; Pedro F C Vasconcelos; Farshad Guirakhoo; Thomas P Monath
Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.
Virology 2001;290(2):309-19.
2001: Harry Kleanthous; Timothy John Tibbitts; H L Gray; Gwendolyn A Myers; Cynthia K Lee; Thomas H Ermak; Thomas P Monath
Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent.
Vaccine 2001;19(32):4883-95.
2001: Farshad Guirakhoo; Juan Arroyo; Konstantin V Pugachev; Chuck Miller; Zhen-Xi Zhang; Richard Weltzin; KM Georgakopoulos; John Catalan; Simeon W Ocran; K Soike; Marion S Ratterree; Thomas P Monath
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
Journal of virology 2001;75(16):7290-304.
2001: Pedro F C Vasconcelos; E J Luna; Ricardo Galler; L J Silva; Terezinha L M Coimbra; Vera L R S Barros; Thomas P Monath; S G Rodigues; C Laval; Z G Costa; M F Vilela; Cecília L S Santos; Priscila M O Papaiordanou; V A Alves; L D Andrade; H K Sato; E S Rosa; G B Froguas; E Lacava; L M Almeida; Ana Cecília R Cruz; Iray Maria Rocco; Raimunda Telma M Santos; O F Oliva; C M Papaiordanou
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases.
Lancet 2001;358(9276):91-7.
2001: Daniel E Roth; David N Taylor; Robert H Gilman; Rina Meza; U Katz; Christian T Bautista; Lilia Cabrera; Billie Velapatiño; Carlos LeBron; M Razúri; J Watanabe; Thomas P Monath
Posttreatment follow-up of Helicobacter pylori infection using a stool antigen immunoassay.
Clinical and diagnostic laboratory immunology 2001;8(4):718-23.
2001: Thomas P Monath; J Arroyo; C Miller; Farshad Guirakhoo
West Nile virus vaccine.
Current drug targets. Infectious disorders 2001;1(1):37-50.
2001: Violette Sanchez; Sophie Gimenez; J Haensler; C Geoffroy; Bachra Rokbi; Delphine Seguin; Ling Lissolo; B Harris; F Rizvi; H Kleanthous; Thomas P Monath; Michel Cadoz; Bruno Guy
Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones.
FEMS immunology and medical microbiology 2001;30(2):157-65.
2001: Juan Arroyo; Farshad Guirakhoo; S Fenner; Zhen-Xi Zhang; Thomas P Monath; Thomas J Chambers
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Journal of virology 2001;75(2):934-42.
2000: Farshad Guirakhoo; Richard Weltzin; Thomas J Chambers; Zhen-Xi Zhang; K Soike; Marion S Ratterree; Juan Arroyo; KM Georgakopoulos; John Catalan; Thomas P Monath
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Journal of virology 2000;74(12):5477-85.
2000: Richard Weltzin; B Guy; W D Thomas; Paul J Giannasca; Thomas P Monath
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Infection and immunity 2000;68(5):2775-82.
2000: Tejal R Bhatt; Mary B Crabtree; Farshad Guirakhoo; Thomas P Monath; Barry R Miller
Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes.
The American journal of tropical medicine and hygiene 2000;62(4):480-4.
2000: Thomas P Monath; Inessa Levenbook; K Soike; Zhen-Xi Zhang; Marion S Ratterree; Ken Draper; Alan D T Barrett; Richard Nichols; Richard Weltzin; Juan Arroyo; Farshad Guirakhoo
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
Journal of virology 2000;74(4):1742-51.
1999: Cynthia K Lee; K Soike; Paul J Giannasca; J Hill; Richard Weltzin; Harry Kleanthous; J Blanchard; Thomas P Monath
Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.
Vaccine 1999;17(23-24):3072-82.
1999: Richard Weltzin; Thomas P Monath
Intranasal antibody prophylaxis for protection against viral disease.
Clinical microbiology reviews 1999;12(3):383-93.
1999: Farshad Guirakhoo; Zhen-Xi Zhang; Thomas J Chambers; Simon Delagrave; Juan Arroyo; Alan D T Barrett; Thomas P Monath
Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Virology 1999;257(2):363-72.
1999: Thomas P Monath; K Soike; Inessa Levenbook; Zhen-Xi Zhang; Juan Arroyo; Simon Delagrave; G Myers; Alan D T Barrett; Robert E Shope; Marion S Ratterree; Thomas J Chambers; Farshad Guirakhoo
Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Vaccine 1999;17(15-16):1869-82.
1999: Yelda Leal-Herrera; Javier Torres; Guillermo I Perez-Perez; Alejandro Gomez; Thomas P Monath; Roberto Tapia-Conyer; Onofre Muñoz
Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico.
The American journal of tropical medicine and hygiene 1999;60(4):587-92.
1999: Simon Delagrave; John Catalan; Charles Sweet; G Drabik; A Henry; A Rees; Thomas P Monath; Farshad Guirakhoo
Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus.
Protein engineering 1999;12(4):357-62.
1999: Cynthia K Lee; K Soike; J Hill; KM Georgakopoulos; Timothy John Tibbitts; JW Ingrassia; H Gray; J Boden; Harry Kleanthous; Paul J Giannasca; Thomas H Ermak; Richard Weltzin; J Blanchard; Thomas P Monath
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Vaccine 1999;17(11-12):1493-505.
1999: Gwendolyn A Myers; Thomas H Ermak; KM Georgakopoulos; Timothy John Tibbitts; JW Ingrassia; H Gray; Harry Kleanthous; Cynthia K Lee; Thomas P Monath
Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
Vaccine 1999;17(11-12):1394-403.
1999: S I Becker; Roger Smalligan; J D Frame; Harry Kleanthous; Timothy John Tibbitts; Thomas P Monath; KC Hyams
Risk of Helicobacter pylori infection among long-term residents in developing countries.
The American journal of tropical medicine and hygiene 1999;60(2):267-70.
1999: Paul J Giannasca; Z X Zhang; W D Lei; J A Boden; M A Giel; Thomas P Monath; W D Thomas
Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
Infection and immunity 1999;67(2):527-38.
1998: Thomas H Ermak; Paul J Giannasca; Richard Nichols; Gwendolyn A Myers; J Nedrud; Richard Weltzin; Cynthia K Lee; Harry Kleanthous; Thomas P Monath
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
The Journal of experimental medicine 1998;188(12):2277-88.
1998: Harry Kleanthous; Gwendolyn A Myers; KM Georgakopoulos; Timothy John Tibbitts; JW Ingrassia; H L Gray; R Ding; Z Z Zhang; W Lei; Richard Nichols; Cynthia K Lee; Thomas H Ermak; Thomas P Monath
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
Infection and immunity 1998;66(6):2879-86.
1998: Harry Kleanthous; Cynthia K Lee; Thomas P Monath
Vaccine development against infection with Helicobacter pylori.
British medical bulletin 1998;54(1):229-41.
1997: Thomas H Ermak; R Ding; B Ekstein; J Hill; Gwendolyn A Myers; Cynthia K Lee; J Pappo; Harry Kleanthous; Thomas P Monath
Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria.
Gastroenterology 1997;113(4):1118-28.
1997: Paul J Giannasca; J A Boden; Thomas P Monath
Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins.
Infection and immunity 1997;65(10):4288-98.
1997: Richard Weltzin; Harry Kleanthous; Farshad Guirakhoo; Thomas P Monath; Cynthia K Lee
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
Vaccine 1997;15(4):370-6.
1996: Farshad Guirakhoo; J Catalan; Thomas P Monath; Richard Weltzin
Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus.
Immunotechnology : an international journal of immunological engineering 1996;2(3):219-28.
1996: Richard Weltzin; V Traina-Dorge; K Soike; J Y Zhang; P Mack; G Soman; G Drabik; Thomas P Monath
Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection.
The Journal of infectious diseases 1996;174(2):256-61.
1995: J F Torres; D M Lyerly; J E Hill; Thomas P Monath
Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.
Infection and immunity 1995;63(12):4619-27.
1995: Cynthia K Lee; Richard Weltzin; W D Thomas; Harry Kleanthous; Thomas H Ermak; G Soman; J E Hill; S K Ackerman; Thomas P Monath
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
The Journal of infectious diseases 1995;172(1):161-72.
1994: Richard Weltzin; S A Hsu; E S Mittler; KM Georgakopoulos; Thomas P Monath
Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.
Antimicrobial agents and chemotherapy 1994;38(12):2785-91.
1994: Cynthia K Lee; Richard Weltzin; G Soman; KM Georgakopoulos; D M Houle; Thomas P Monath
Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice.
Infection and immunity 1994;62(3):887-91.